nodes	percent_of_prediction	percent_of_DWPC	metapath
Budesonide—CYP3A4—Topotecan—lung cancer	0.0713	0.142	CbGbCtD
Budesonide—CYP3A4—Gefitinib—lung cancer	0.0652	0.13	CbGbCtD
Budesonide—CYP3A4—Teniposide—lung cancer	0.0632	0.126	CbGbCtD
Budesonide—CYP3A4—Vinorelbine—lung cancer	0.0502	0.1	CbGbCtD
Budesonide—CYP3A4—Crizotinib—lung cancer	0.04	0.0796	CbGbCtD
Budesonide—CYP3A4—Erlotinib—lung cancer	0.0386	0.0768	CbGbCtD
Budesonide—CYP3A4—Paclitaxel—lung cancer	0.0353	0.0703	CbGbCtD
Budesonide—CYP3A4—Irinotecan—lung cancer	0.0348	0.0694	CbGbCtD
Budesonide—CYP3A4—Vinblastine—lung cancer	0.031	0.0617	CbGbCtD
Budesonide—CYP3A4—Etoposide—lung cancer	0.0279	0.0556	CbGbCtD
Budesonide—CYP3A4—Docetaxel—lung cancer	0.0255	0.0508	CbGbCtD
Budesonide—CYP3A4—Doxorubicin—lung cancer	0.019	0.0379	CbGbCtD
Budesonide—Amcinonide—ANXA1—lung cancer	0.00289	0.316	CrCbGaD
Budesonide—NR3C1—Nuclear Receptors—RARB—lung cancer	0.00132	0.0169	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—NKX2-1—lung cancer	0.00126	0.0161	CbGpPWpGaD
Budesonide—Hydrocortisone—ANXA1—lung cancer	0.00122	0.133	CrCbGaD
Budesonide—NR3C1—Endoderm Differentiation—NODAL—lung cancer	0.00107	0.0137	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.00106	0.0135	CbGpPWpGaD
Budesonide—NR3C1—Nuclear Receptor transcription pathway—RARB—lung cancer	0.00105	0.0134	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.001	0.0128	CbGpPWpGaD
Budesonide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.000917	0.0117	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000912	0.0117	CbGpPWpGaD
Budesonide—Dexamethasone—ANXA1—lung cancer	0.000909	0.0994	CrCbGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—lung cancer	0.000901	0.0115	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000882	0.0113	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—lung cancer	0.000869	0.0111	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000869	0.0111	CbGpPWpGaD
Budesonide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000848	0.0109	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.00082	0.0105	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—lung cancer	0.000819	0.0105	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—SOX2—lung cancer	0.000811	0.0104	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—NPPA—lung cancer	0.000792	0.0101	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—lung cancer	0.000777	0.00994	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—ATF3—lung cancer	0.00075	0.00959	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.000734	0.00939	CbGpPWpGaD
Budesonide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.000711	0.00909	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—PTHLH—lung cancer	0.000689	0.00882	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.000687	0.00879	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—SFN—lung cancer	0.000676	0.00865	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—lung cancer	0.000667	0.00854	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000624	0.00799	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—lung cancer	0.000622	0.00796	CbGpPWpGaD
Budesonide—NR3C1—Endoderm Differentiation—APP—lung cancer	0.000614	0.00786	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000614	0.00786	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.000592	0.00757	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000591	0.00756	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IRF1—lung cancer	0.000581	0.00743	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000577	0.00738	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUNB—lung cancer	0.000568	0.00727	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—AVP—lung cancer	0.000566	0.00724	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000562	0.00719	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.00055	0.00704	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000524	0.0067	CbGpPWpGaD
Budesonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—lung cancer	0.000523	0.00669	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000522	0.00668	CbGpPWpGaD
Budesonide—Clobetasol propionate—CYP1A1—lung cancer	0.000522	0.0571	CrCbGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.000518	0.00662	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000517	0.00662	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—lung cancer	0.000503	0.00644	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000502	0.00642	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—AHR—lung cancer	0.000495	0.00634	CbGpPWpGaD
Budesonide—Prednisolone—CYP2A6—lung cancer	0.000489	0.0535	CrCbGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000479	0.00613	CbGpPWpGaD
Budesonide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000464	0.00594	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000449	0.00574	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—HIF1A—lung cancer	0.000449	0.00574	CbGpPWpGaD
Budesonide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000448	0.00574	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.000443	0.00567	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000439	0.00562	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.000439	0.00561	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000433	0.00554	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000431	0.00551	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000422	0.00539	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000417	0.00534	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—LMNA—lung cancer	0.00041	0.00525	CbGpPWpGaD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.00041	0.00525	CbGpPWpGaD
Budesonide—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000408	0.00522	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000404	0.00517	CbGpPWpGaD
Budesonide—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.000391	0.005	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.000391	0.005	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.000377	0.00483	CbGpPWpGaD
Budesonide—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000375	0.0048	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.000373	0.00477	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.00037	0.00473	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—CREBBP—lung cancer	0.000366	0.00469	CbGpPWpGaD
Budesonide—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000361	0.00462	CbGpPWpGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000356	0.00455	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.000355	0.00454	CbGpPWpGaD
Budesonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.000343	0.00438	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000342	0.00437	CbGpPWpGaD
Budesonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.00034	0.00435	CbGpPWpGaD
Budesonide—Hydrocortisone—ABCG2—lung cancer	0.000335	0.0366	CrCbGaD
Budesonide—NR3C1—Endoderm Differentiation—APC—lung cancer	0.000334	0.00427	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.000329	0.00421	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.000321	0.0041	CbGpPWpGaD
Budesonide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.00028	0.00358	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2A6—lung cancer	0.000279	0.0305	CrCbGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.000279	0.00357	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.000273	0.0035	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.000269	0.00344	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000268	0.00343	CbGpPWpGaD
Budesonide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000267	0.00341	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000266	0.00341	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000265	0.00338	CbGpPWpGaD
Budesonide—Methylprednisolone—ABCB1—lung cancer	0.000258	0.0283	CrCbGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.000257	0.00329	CbGpPWpGaD
Budesonide—Triamcinolone—PTGS2—lung cancer	0.000256	0.028	CrCbGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000255	0.00326	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000252	0.00322	CbGpPWpGaD
Budesonide—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.00025	0.0032	CbGpPWpGaD
Budesonide—NR3C1—Circadian Clock—EP300—lung cancer	0.00025	0.00319	CbGpPWpGaD
Budesonide—Dexamethasone—ABCG2—lung cancer	0.000249	0.0273	CrCbGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000246	0.00315	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.00024	0.00307	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000232	0.00297	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000231	0.00296	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000229	0.00293	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000226	0.00289	CbGpPWpGaD
Budesonide—NR3C1—Adipogenesis—HIF1A—lung cancer	0.000225	0.00288	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.000225	0.00288	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000224	0.00286	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000223	0.00285	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000217	0.00278	CbGpPWpGaD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000217	0.00277	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000216	0.00276	CbGpPWpGaD
Budesonide—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000215	0.00275	CbGpPWpGaD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000214	0.00274	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.000211	0.0027	CbGpPWpGaD
Budesonide—Betamethasone—PTGS2—lung cancer	0.00021	0.023	CrCbGaD
Budesonide—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000209	0.00267	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000209	0.00267	CbGpPWpGaD
Budesonide—Prednisone—ALB—lung cancer	0.000207	0.0226	CrCbGaD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000207	0.00264	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000206	0.00264	CbGpPWpGaD
Budesonide—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000206	0.00263	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000202	0.00258	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000198	0.00254	CbGpPWpGaD
Budesonide—Dexamethasone—CYP2E1—lung cancer	0.000198	0.0217	CrCbGaD
Budesonide—Prednisone—ABCB1—lung cancer	0.000198	0.0216	CrCbGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000197	0.00251	CbGpPWpGaD
Budesonide—Decreased appetite—Etoposide—lung cancer	0.000196	0.000476	CcSEcCtD
Budesonide—Dexamethasone—CYP1A1—lung cancer	0.000195	0.0214	CrCbGaD
Budesonide—Chest pain—Docetaxel—lung cancer	0.000195	0.000475	CcSEcCtD
Budesonide—Arthralgia—Docetaxel—lung cancer	0.000195	0.000475	CcSEcCtD
Budesonide—Myalgia—Docetaxel—lung cancer	0.000195	0.000475	CcSEcCtD
Budesonide—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000195	0.00249	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000195	0.00249	CbGpPWpGaD
Budesonide—Nausea—Vinorelbine—lung cancer	0.000195	0.000474	CcSEcCtD
Budesonide—Gastrointestinal disorder—Etoposide—lung cancer	0.000194	0.000473	CcSEcCtD
Budesonide—Dyspepsia—Paclitaxel—lung cancer	0.000194	0.000473	CcSEcCtD
Budesonide—Body temperature increased—Cisplatin—lung cancer	0.000194	0.000473	CcSEcCtD
Budesonide—Asthenia—Irinotecan—lung cancer	0.000194	0.000472	CcSEcCtD
Budesonide—Fatigue—Etoposide—lung cancer	0.000194	0.000472	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000194	0.000472	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000193	0.00246	CbGpPWpGaD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000192	0.00246	CbGpPWpGaD
Budesonide—Constipation—Etoposide—lung cancer	0.000192	0.000468	CcSEcCtD
Budesonide—Pain—Etoposide—lung cancer	0.000192	0.000468	CcSEcCtD
Budesonide—Dysuria—Doxorubicin—lung cancer	0.000192	0.000467	CcSEcCtD
Budesonide—Decreased appetite—Paclitaxel—lung cancer	0.000192	0.000467	CcSEcCtD
Budesonide—Dry mouth—Docetaxel—lung cancer	0.000191	0.000464	CcSEcCtD
Budesonide—Haemoglobin—Methotrexate—lung cancer	0.000191	0.000464	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000191	0.00244	CbGpPWpGaD
Budesonide—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00019	0.000464	CcSEcCtD
Budesonide—Fatigue—Paclitaxel—lung cancer	0.00019	0.000463	CcSEcCtD
Budesonide—Haemorrhage—Methotrexate—lung cancer	0.00019	0.000462	CcSEcCtD
Budesonide—Pollakiuria—Doxorubicin—lung cancer	0.00019	0.000461	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.000189	0.00242	CbGpPWpGaD
Budesonide—Asthenia—Gemcitabine—lung cancer	0.000189	0.00046	CcSEcCtD
Budesonide—Constipation—Paclitaxel—lung cancer	0.000189	0.000459	CcSEcCtD
Budesonide—Pain—Paclitaxel—lung cancer	0.000189	0.000459	CcSEcCtD
Budesonide—Confusional state—Docetaxel—lung cancer	0.000189	0.000459	CcSEcCtD
Budesonide—Pharyngitis—Methotrexate—lung cancer	0.000188	0.000458	CcSEcCtD
Budesonide—Urinary tract disorder—Methotrexate—lung cancer	0.000187	0.000456	CcSEcCtD
Budesonide—Anaphylactic shock—Docetaxel—lung cancer	0.000187	0.000455	CcSEcCtD
Budesonide—Weight increased—Doxorubicin—lung cancer	0.000187	0.000455	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000186	0.00239	CbGpPWpGaD
Budesonide—Pruritus—Gemcitabine—lung cancer	0.000186	0.000454	CcSEcCtD
Budesonide—Urethral disorder—Methotrexate—lung cancer	0.000186	0.000453	CcSEcCtD
Budesonide—Infection—Docetaxel—lung cancer	0.000186	0.000452	CcSEcCtD
Budesonide—Feeling abnormal—Etoposide—lung cancer	0.000185	0.000451	CcSEcCtD
Budesonide—Diarrhoea—Irinotecan—lung cancer	0.000185	0.000451	CcSEcCtD
Budesonide—Gastrointestinal pain—Etoposide—lung cancer	0.000184	0.000448	CcSEcCtD
Budesonide—Shock—Docetaxel—lung cancer	0.000184	0.000448	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—RB1—lung cancer	0.000183	0.00235	CbGpPWpGaD
Budesonide—Nervous system disorder—Docetaxel—lung cancer	0.000183	0.000446	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000183	0.00234	CbGpPWpGaD
Budesonide—Infestation NOS—Doxorubicin—lung cancer	0.000183	0.000445	CcSEcCtD
Budesonide—Infestation—Doxorubicin—lung cancer	0.000183	0.000445	CcSEcCtD
Budesonide—Visual impairment—Methotrexate—lung cancer	0.000183	0.000445	CcSEcCtD
Budesonide—Tachycardia—Docetaxel—lung cancer	0.000182	0.000444	CcSEcCtD
Budesonide—Prednisolone—ABCB1—lung cancer	0.000182	0.0199	CrCbGaD
Budesonide—Feeling abnormal—Paclitaxel—lung cancer	0.000182	0.000443	CcSEcCtD
Budesonide—Skin disorder—Docetaxel—lung cancer	0.000182	0.000442	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000181	0.00232	CbGpPWpGaD
Budesonide—Hypersensitivity—Cisplatin—lung cancer	0.000181	0.00044	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000181	0.00231	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Paclitaxel—lung cancer	0.00018	0.000439	CcSEcCtD
Budesonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.00018	0.00231	CbGpPWpGaD
Budesonide—Diarrhoea—Gemcitabine—lung cancer	0.00018	0.000439	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000179	0.00229	CbGpPWpGaD
Budesonide—Dizziness—Irinotecan—lung cancer	0.000179	0.000435	CcSEcCtD
Budesonide—Urticaria—Etoposide—lung cancer	0.000179	0.000435	CcSEcCtD
Budesonide—Betamethasone—ABCB1—lung cancer	0.000178	0.0195	CrCbGaD
Budesonide—Anorexia—Docetaxel—lung cancer	0.000178	0.000434	CcSEcCtD
Budesonide—Body temperature increased—Etoposide—lung cancer	0.000178	0.000433	CcSEcCtD
Budesonide—Abdominal pain—Etoposide—lung cancer	0.000178	0.000433	CcSEcCtD
Budesonide—Conjunctivitis—Doxorubicin—lung cancer	0.000178	0.000433	CcSEcCtD
Budesonide—Urinary tract infection—Doxorubicin—lung cancer	0.000178	0.000433	CcSEcCtD
Budesonide—Eye disorder—Methotrexate—lung cancer	0.000177	0.000432	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000176	0.00225	CbGpPWpGaD
Budesonide—Asthenia—Cisplatin—lung cancer	0.000176	0.000429	CcSEcCtD
Budesonide—Cardiac disorder—Methotrexate—lung cancer	0.000176	0.000429	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000176	0.00225	CbGpPWpGaD
Budesonide—Urticaria—Paclitaxel—lung cancer	0.000175	0.000427	CcSEcCtD
Budesonide—Haematuria—Doxorubicin—lung cancer	0.000174	0.000425	CcSEcCtD
Budesonide—Abdominal pain—Paclitaxel—lung cancer	0.000174	0.000425	CcSEcCtD
Budesonide—Body temperature increased—Paclitaxel—lung cancer	0.000174	0.000425	CcSEcCtD
Budesonide—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000174	0.00222	CbGpPWpGaD
Budesonide—Epistaxis—Doxorubicin—lung cancer	0.000173	0.00042	CcSEcCtD
Budesonide—Angiopathy—Methotrexate—lung cancer	0.000172	0.000419	CcSEcCtD
Budesonide—Vomiting—Irinotecan—lung cancer	0.000172	0.000419	CcSEcCtD
Budesonide—Sinusitis—Doxorubicin—lung cancer	0.000172	0.000418	CcSEcCtD
Budesonide—Immune system disorder—Methotrexate—lung cancer	0.000171	0.000417	CcSEcCtD
Budesonide—Mediastinal disorder—Methotrexate—lung cancer	0.000171	0.000416	CcSEcCtD
Budesonide—Rash—Irinotecan—lung cancer	0.000171	0.000415	CcSEcCtD
Budesonide—Dermatitis—Irinotecan—lung cancer	0.00017	0.000415	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.00017	0.000415	CcSEcCtD
Budesonide—Headache—Irinotecan—lung cancer	0.000169	0.000412	CcSEcCtD
Budesonide—Insomnia—Docetaxel—lung cancer	0.000169	0.000412	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000169	0.00216	CbGpPWpGaD
Budesonide—Diarrhoea—Cisplatin—lung cancer	0.000168	0.000409	CcSEcCtD
Budesonide—Paraesthesia—Docetaxel—lung cancer	0.000168	0.000409	CcSEcCtD
Budesonide—Alopecia—Methotrexate—lung cancer	0.000168	0.000408	CcSEcCtD
Budesonide—Vomiting—Gemcitabine—lung cancer	0.000168	0.000408	CcSEcCtD
Budesonide—Dyspnoea—Docetaxel—lung cancer	0.000167	0.000406	CcSEcCtD
Budesonide—Somnolence—Docetaxel—lung cancer	0.000166	0.000405	CcSEcCtD
Budesonide—Mental disorder—Methotrexate—lung cancer	0.000166	0.000405	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000166	0.00213	CbGpPWpGaD
Budesonide—Rash—Gemcitabine—lung cancer	0.000166	0.000404	CcSEcCtD
Budesonide—Dermatitis—Gemcitabine—lung cancer	0.000166	0.000404	CcSEcCtD
Budesonide—Hypersensitivity—Etoposide—lung cancer	0.000166	0.000404	CcSEcCtD
Budesonide—Malnutrition—Methotrexate—lung cancer	0.000165	0.000402	CcSEcCtD
Budesonide—Haemoglobin—Doxorubicin—lung cancer	0.000165	0.000402	CcSEcCtD
Budesonide—Headache—Gemcitabine—lung cancer	0.000165	0.000402	CcSEcCtD
Budesonide—Rhinitis—Doxorubicin—lung cancer	0.000165	0.000401	CcSEcCtD
Budesonide—Dyspepsia—Docetaxel—lung cancer	0.000165	0.000401	CcSEcCtD
Budesonide—Haemorrhage—Doxorubicin—lung cancer	0.000164	0.0004	CcSEcCtD
Budesonide—Pharyngitis—Doxorubicin—lung cancer	0.000163	0.000397	CcSEcCtD
Budesonide—Decreased appetite—Docetaxel—lung cancer	0.000163	0.000396	CcSEcCtD
Budesonide—Hypersensitivity—Paclitaxel—lung cancer	0.000163	0.000396	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000162	0.00208	CbGpPWpGaD
Budesonide—Urinary tract disorder—Doxorubicin—lung cancer	0.000162	0.000395	CcSEcCtD
Budesonide—Oedema peripheral—Doxorubicin—lung cancer	0.000162	0.000394	CcSEcCtD
Budesonide—Dysgeusia—Methotrexate—lung cancer	0.000162	0.000394	CcSEcCtD
Budesonide—Gastrointestinal disorder—Docetaxel—lung cancer	0.000161	0.000393	CcSEcCtD
Budesonide—Asthenia—Etoposide—lung cancer	0.000161	0.000393	CcSEcCtD
Budesonide—Connective tissue disorder—Doxorubicin—lung cancer	0.000161	0.000393	CcSEcCtD
Budesonide—Fatigue—Docetaxel—lung cancer	0.000161	0.000392	CcSEcCtD
Budesonide—Urethral disorder—Doxorubicin—lung cancer	0.000161	0.000392	CcSEcCtD
Budesonide—Nausea—Irinotecan—lung cancer	0.000161	0.000391	CcSEcCtD
Budesonide—Constipation—Docetaxel—lung cancer	0.00016	0.000389	CcSEcCtD
Budesonide—Pain—Docetaxel—lung cancer	0.00016	0.000389	CcSEcCtD
Budesonide—Back pain—Methotrexate—lung cancer	0.00016	0.000389	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.00016	0.00204	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000159	0.00204	CbGpPWpGaD
Budesonide—Pruritus—Etoposide—lung cancer	0.000159	0.000387	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000159	0.00204	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—KHSRP—lung cancer	0.000159	0.00203	CbGpPWpGaD
Budesonide—Visual impairment—Doxorubicin—lung cancer	0.000158	0.000385	CcSEcCtD
Budesonide—Asthenia—Paclitaxel—lung cancer	0.000158	0.000385	CcSEcCtD
Budesonide—Nausea—Gemcitabine—lung cancer	0.000157	0.000381	CcSEcCtD
Budesonide—Vomiting—Cisplatin—lung cancer	0.000156	0.00038	CcSEcCtD
Budesonide—Pruritus—Paclitaxel—lung cancer	0.000156	0.00038	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000156	0.00199	CbGpPWpGaD
Budesonide—Vision blurred—Methotrexate—lung cancer	0.000156	0.000379	CcSEcCtD
Budesonide—Rash—Cisplatin—lung cancer	0.000155	0.000377	CcSEcCtD
Budesonide—Dermatitis—Cisplatin—lung cancer	0.000155	0.000377	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000154	0.00197	CbGpPWpGaD
Budesonide—Feeling abnormal—Docetaxel—lung cancer	0.000154	0.000375	CcSEcCtD
Budesonide—Diarrhoea—Etoposide—lung cancer	0.000154	0.000375	CcSEcCtD
Budesonide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000154	0.00197	CbGpPWpGaD
Budesonide—Eye disorder—Doxorubicin—lung cancer	0.000154	0.000374	CcSEcCtD
Budesonide—Ill-defined disorder—Methotrexate—lung cancer	0.000153	0.000373	CcSEcCtD
Budesonide—Gastrointestinal pain—Docetaxel—lung cancer	0.000153	0.000372	CcSEcCtD
Budesonide—Anaemia—Methotrexate—lung cancer	0.000153	0.000372	CcSEcCtD
Budesonide—Cardiac disorder—Doxorubicin—lung cancer	0.000152	0.000371	CcSEcCtD
Budesonide—Flushing—Doxorubicin—lung cancer	0.000152	0.000371	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000152	0.00194	CbGpPWpGaD
Budesonide—Diarrhoea—Paclitaxel—lung cancer	0.000151	0.000367	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.00015	0.00192	CbGpPWpGaD
Budesonide—Angiopathy—Doxorubicin—lung cancer	0.000149	0.000363	CcSEcCtD
Budesonide—Malaise—Methotrexate—lung cancer	0.000149	0.000362	CcSEcCtD
Budesonide—Dizziness—Etoposide—lung cancer	0.000149	0.000362	CcSEcCtD
Budesonide—Immune system disorder—Doxorubicin—lung cancer	0.000148	0.000361	CcSEcCtD
Budesonide—Vertigo—Methotrexate—lung cancer	0.000148	0.000361	CcSEcCtD
Budesonide—Mediastinal disorder—Doxorubicin—lung cancer	0.000148	0.00036	CcSEcCtD
Budesonide—Abdominal pain—Docetaxel—lung cancer	0.000148	0.00036	CcSEcCtD
Budesonide—Body temperature increased—Docetaxel—lung cancer	0.000148	0.00036	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000147	0.00188	CbGpPWpGaD
Budesonide—Dizziness—Paclitaxel—lung cancer	0.000146	0.000355	CcSEcCtD
Budesonide—Nausea—Cisplatin—lung cancer	0.000146	0.000355	CcSEcCtD
Budesonide—Alopecia—Doxorubicin—lung cancer	0.000145	0.000353	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000145	0.00185	CbGpPWpGaD
Budesonide—Cough—Methotrexate—lung cancer	0.000144	0.000351	CcSEcCtD
Budesonide—Mental disorder—Doxorubicin—lung cancer	0.000144	0.00035	CcSEcCtD
Budesonide—Vomiting—Etoposide—lung cancer	0.000143	0.000348	CcSEcCtD
Budesonide—Malnutrition—Doxorubicin—lung cancer	0.000143	0.000348	CcSEcCtD
Budesonide—Rash—Etoposide—lung cancer	0.000142	0.000345	CcSEcCtD
Budesonide—Dermatitis—Etoposide—lung cancer	0.000142	0.000345	CcSEcCtD
Budesonide—Headache—Etoposide—lung cancer	0.000141	0.000343	CcSEcCtD
Budesonide—Flatulence—Doxorubicin—lung cancer	0.000141	0.000343	CcSEcCtD
Budesonide—Myalgia—Methotrexate—lung cancer	0.000141	0.000342	CcSEcCtD
Budesonide—Chest pain—Methotrexate—lung cancer	0.000141	0.000342	CcSEcCtD
Budesonide—Arthralgia—Methotrexate—lung cancer	0.000141	0.000342	CcSEcCtD
Budesonide—Tension—Doxorubicin—lung cancer	0.00014	0.000342	CcSEcCtD
Budesonide—Vomiting—Paclitaxel—lung cancer	0.00014	0.000341	CcSEcCtD
Budesonide—Dysgeusia—Doxorubicin—lung cancer	0.00014	0.000341	CcSEcCtD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00014	0.00034	CcSEcCtD
Budesonide—Hydrocortisone—ABCB1—lung cancer	0.000139	0.0152	CrCbGaD
Budesonide—Rash—Paclitaxel—lung cancer	0.000139	0.000339	CcSEcCtD
Budesonide—Dermatitis—Paclitaxel—lung cancer	0.000139	0.000338	CcSEcCtD
Budesonide—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000139	0.00178	CbGpPWpGaD
Budesonide—Discomfort—Methotrexate—lung cancer	0.000139	0.000338	CcSEcCtD
Budesonide—Nervousness—Doxorubicin—lung cancer	0.000139	0.000338	CcSEcCtD
Budesonide—Back pain—Doxorubicin—lung cancer	0.000138	0.000337	CcSEcCtD
Budesonide—Headache—Paclitaxel—lung cancer	0.000138	0.000336	CcSEcCtD
Budesonide—Hypersensitivity—Docetaxel—lung cancer	0.000138	0.000335	CcSEcCtD
Budesonide—Muscle spasms—Doxorubicin—lung cancer	0.000137	0.000335	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000137	0.00175	CbGpPWpGaD
Budesonide—Confusional state—Methotrexate—lung cancer	0.000136	0.000331	CcSEcCtD
Budesonide—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000135	0.00172	CbGpPWpGaD
Budesonide—Anaphylactic shock—Methotrexate—lung cancer	0.000135	0.000328	CcSEcCtD
Budesonide—Vision blurred—Doxorubicin—lung cancer	0.000135	0.000328	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000135	0.00172	CbGpPWpGaD
Budesonide—Asthenia—Docetaxel—lung cancer	0.000134	0.000327	CcSEcCtD
Budesonide—Infection—Methotrexate—lung cancer	0.000134	0.000326	CcSEcCtD
Budesonide—Nausea—Etoposide—lung cancer	0.000134	0.000325	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000134	0.00171	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000133	0.0017	CbGpPWpGaD
Budesonide—Ill-defined disorder—Doxorubicin—lung cancer	0.000133	0.000323	CcSEcCtD
Budesonide—Pruritus—Docetaxel—lung cancer	0.000132	0.000322	CcSEcCtD
Budesonide—Nervous system disorder—Methotrexate—lung cancer	0.000132	0.000322	CcSEcCtD
Budesonide—Anaemia—Doxorubicin—lung cancer	0.000132	0.000322	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000132	0.00169	CbGpPWpGaD
Budesonide—Agitation—Doxorubicin—lung cancer	0.000131	0.00032	CcSEcCtD
Budesonide—Nausea—Paclitaxel—lung cancer	0.000131	0.000319	CcSEcCtD
Budesonide—Skin disorder—Methotrexate—lung cancer	0.000131	0.000319	CcSEcCtD
Budesonide—Hyperhidrosis—Methotrexate—lung cancer	0.00013	0.000317	CcSEcCtD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.00013	0.00166	CbGpPWpGaD
Budesonide—Malaise—Doxorubicin—lung cancer	0.000129	0.000314	CcSEcCtD
Budesonide—Vertigo—Doxorubicin—lung cancer	0.000128	0.000313	CcSEcCtD
Budesonide—Anorexia—Methotrexate—lung cancer	0.000128	0.000313	CcSEcCtD
Budesonide—Syncope—Doxorubicin—lung cancer	0.000128	0.000312	CcSEcCtD
Budesonide—Diarrhoea—Docetaxel—lung cancer	0.000128	0.000311	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000126	0.00162	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000126	0.00162	CbGpPWpGaD
Budesonide—Palpitations—Doxorubicin—lung cancer	0.000126	0.000308	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000126	0.00162	CbGpPWpGaD
Budesonide—Loss of consciousness—Doxorubicin—lung cancer	0.000126	0.000306	CcSEcCtD
Budesonide—NR3C1—Gene Expression—DICER1—lung cancer	0.000126	0.00161	CbGpPWpGaD
Budesonide—Cough—Doxorubicin—lung cancer	0.000125	0.000304	CcSEcCtD
Budesonide—Dizziness—Docetaxel—lung cancer	0.000124	0.000301	CcSEcCtD
Budesonide—Hypertension—Doxorubicin—lung cancer	0.000123	0.000301	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000123	0.000299	CcSEcCtD
Budesonide—Dexamethasone—PTGS2—lung cancer	0.000122	0.0134	CrCbGaD
Budesonide—Insomnia—Methotrexate—lung cancer	0.000122	0.000297	CcSEcCtD
Budesonide—Myalgia—Doxorubicin—lung cancer	0.000122	0.000296	CcSEcCtD
Budesonide—Arthralgia—Doxorubicin—lung cancer	0.000122	0.000296	CcSEcCtD
Budesonide—Chest pain—Doxorubicin—lung cancer	0.000122	0.000296	CcSEcCtD
Budesonide—Anxiety—Doxorubicin—lung cancer	0.000121	0.000295	CcSEcCtD
Budesonide—Paraesthesia—Methotrexate—lung cancer	0.000121	0.000295	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000121	0.00155	CbGpPWpGaD
Budesonide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000121	0.000294	CcSEcCtD
Budesonide—Discomfort—Doxorubicin—lung cancer	0.00012	0.000293	CcSEcCtD
Budesonide—Dyspnoea—Methotrexate—lung cancer	0.00012	0.000292	CcSEcCtD
Budesonide—Somnolence—Methotrexate—lung cancer	0.00012	0.000292	CcSEcCtD
Budesonide—Dry mouth—Doxorubicin—lung cancer	0.000119	0.00029	CcSEcCtD
Budesonide—Vomiting—Docetaxel—lung cancer	0.000119	0.000289	CcSEcCtD
Budesonide—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000119	0.00152	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.000119	0.00152	CbGpPWpGaD
Budesonide—Dyspepsia—Methotrexate—lung cancer	0.000119	0.000289	CcSEcCtD
Budesonide—Rash—Docetaxel—lung cancer	0.000118	0.000287	CcSEcCtD
Budesonide—Dermatitis—Docetaxel—lung cancer	0.000118	0.000287	CcSEcCtD
Budesonide—Confusional state—Doxorubicin—lung cancer	0.000118	0.000286	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—STAT3—lung cancer	0.000118	0.0015	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	0.000118	0.0015	CbGpPWpGaD
Budesonide—Decreased appetite—Methotrexate—lung cancer	0.000117	0.000285	CcSEcCtD
Budesonide—Headache—Docetaxel—lung cancer	0.000117	0.000285	CcSEcCtD
Budesonide—Anaphylactic shock—Doxorubicin—lung cancer	0.000117	0.000284	CcSEcCtD
Budesonide—Gastrointestinal disorder—Methotrexate—lung cancer	0.000116	0.000283	CcSEcCtD
Budesonide—Fatigue—Methotrexate—lung cancer	0.000116	0.000283	CcSEcCtD
Budesonide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000116	0.00149	CbGpPWpGaD
Budesonide—Infection—Doxorubicin—lung cancer	0.000116	0.000282	CcSEcCtD
Budesonide—Pain—Methotrexate—lung cancer	0.000115	0.000281	CcSEcCtD
Budesonide—Shock—Doxorubicin—lung cancer	0.000115	0.000279	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—HPGDS—lung cancer	0.000115	0.00147	CbGpPWpGaD
Budesonide—Nervous system disorder—Doxorubicin—lung cancer	0.000114	0.000279	CcSEcCtD
Budesonide—Tachycardia—Doxorubicin—lung cancer	0.000114	0.000277	CcSEcCtD
Budesonide—Skin disorder—Doxorubicin—lung cancer	0.000113	0.000276	CcSEcCtD
Budesonide—Hyperhidrosis—Doxorubicin—lung cancer	0.000113	0.000275	CcSEcCtD
Budesonide—Anorexia—Doxorubicin—lung cancer	0.000111	0.000271	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTT1—lung cancer	0.000111	0.00142	CbGpPWpGaD
Budesonide—Nausea—Docetaxel—lung cancer	0.000111	0.00027	CcSEcCtD
Budesonide—Feeling abnormal—Methotrexate—lung cancer	0.000111	0.00027	CcSEcCtD
Budesonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	0.000111	0.00142	CbGpPWpGaD
Budesonide—Gastrointestinal pain—Methotrexate—lung cancer	0.00011	0.000268	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	0.00011	0.0014	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GCLC—lung cancer	0.00011	0.0014	CbGpPWpGaD
Budesonide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	0.00011	0.0014	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—SKI—lung cancer	0.000108	0.00139	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	0.000108	0.00139	CbGpPWpGaD
Budesonide—Urticaria—Methotrexate—lung cancer	0.000107	0.000261	CcSEcCtD
Budesonide—Body temperature increased—Methotrexate—lung cancer	0.000107	0.000259	CcSEcCtD
Budesonide—Abdominal pain—Methotrexate—lung cancer	0.000107	0.000259	CcSEcCtD
Budesonide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000106	0.000259	CcSEcCtD
Budesonide—Insomnia—Doxorubicin—lung cancer	0.000106	0.000257	CcSEcCtD
Budesonide—Paraesthesia—Doxorubicin—lung cancer	0.000105	0.000255	CcSEcCtD
Budesonide—Dyspnoea—Doxorubicin—lung cancer	0.000104	0.000253	CcSEcCtD
Budesonide—Dexamethasone—ABCB1—lung cancer	0.000104	0.0114	CrCbGaD
Budesonide—Somnolence—Doxorubicin—lung cancer	0.000104	0.000253	CcSEcCtD
Budesonide—Dyspepsia—Doxorubicin—lung cancer	0.000103	0.00025	CcSEcCtD
Budesonide—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	0.000103	0.00131	CbGpPWpGaD
Budesonide—Decreased appetite—Doxorubicin—lung cancer	0.000101	0.000247	CcSEcCtD
Budesonide—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000101	0.000245	CcSEcCtD
Budesonide—Fatigue—Doxorubicin—lung cancer	0.000101	0.000245	CcSEcCtD
Budesonide—Pain—Doxorubicin—lung cancer	9.98e-05	0.000243	CcSEcCtD
Budesonide—Constipation—Doxorubicin—lung cancer	9.98e-05	0.000243	CcSEcCtD
Budesonide—Hypersensitivity—Methotrexate—lung cancer	9.93e-05	0.000242	CcSEcCtD
Budesonide—Asthenia—Methotrexate—lung cancer	9.67e-05	0.000235	CcSEcCtD
Budesonide—Feeling abnormal—Doxorubicin—lung cancer	9.62e-05	0.000234	CcSEcCtD
Budesonide—Gastrointestinal pain—Doxorubicin—lung cancer	9.54e-05	0.000232	CcSEcCtD
Budesonide—Pruritus—Methotrexate—lung cancer	9.53e-05	0.000232	CcSEcCtD
Budesonide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	9.42e-05	0.0012	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	9.34e-05	0.00119	CbGpPWpGaD
Budesonide—Urticaria—Doxorubicin—lung cancer	9.27e-05	0.000226	CcSEcCtD
Budesonide—Body temperature increased—Doxorubicin—lung cancer	9.23e-05	0.000225	CcSEcCtD
Budesonide—Abdominal pain—Doxorubicin—lung cancer	9.23e-05	0.000225	CcSEcCtD
Budesonide—Diarrhoea—Methotrexate—lung cancer	9.22e-05	0.000224	CcSEcCtD
Budesonide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	9.21e-05	0.00118	CbGpPWpGaD
Budesonide—Dizziness—Methotrexate—lung cancer	8.91e-05	0.000217	CcSEcCtD
Budesonide—NR3C1—Gene Expression—RARB—lung cancer	8.71e-05	0.00111	CbGpPWpGaD
Budesonide—Hypersensitivity—Doxorubicin—lung cancer	8.6e-05	0.000209	CcSEcCtD
Budesonide—Vomiting—Methotrexate—lung cancer	8.57e-05	0.000209	CcSEcCtD
Budesonide—Rash—Methotrexate—lung cancer	8.5e-05	0.000207	CcSEcCtD
Budesonide—Dermatitis—Methotrexate—lung cancer	8.49e-05	0.000207	CcSEcCtD
Budesonide—NR3C1—Gene Expression—NPPA—lung cancer	8.49e-05	0.00109	CbGpPWpGaD
Budesonide—Headache—Methotrexate—lung cancer	8.44e-05	0.000206	CcSEcCtD
Budesonide—Asthenia—Doxorubicin—lung cancer	8.37e-05	0.000204	CcSEcCtD
Budesonide—Pruritus—Doxorubicin—lung cancer	8.26e-05	0.000201	CcSEcCtD
Budesonide—NR3C1—Adipogenesis—IL6—lung cancer	8.21e-05	0.00105	CbGpPWpGaD
Budesonide—Nausea—Methotrexate—lung cancer	8.01e-05	0.000195	CcSEcCtD
Budesonide—Diarrhoea—Doxorubicin—lung cancer	7.98e-05	0.000194	CcSEcCtD
Budesonide—Dizziness—Doxorubicin—lung cancer	7.72e-05	0.000188	CcSEcCtD
Budesonide—CYP3A4—Biological oxidations—GSTP1—lung cancer	7.7e-05	0.000985	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	7.59e-05	0.000972	CbGpPWpGaD
Budesonide—Vomiting—Doxorubicin—lung cancer	7.42e-05	0.000181	CcSEcCtD
Budesonide—Rash—Doxorubicin—lung cancer	7.36e-05	0.000179	CcSEcCtD
Budesonide—Dermatitis—Doxorubicin—lung cancer	7.35e-05	0.000179	CcSEcCtD
Budesonide—Headache—Doxorubicin—lung cancer	7.31e-05	0.000178	CcSEcCtD
Budesonide—NR3C1—Gene Expression—HSPB1—lung cancer	7.3e-05	0.000933	CbGpPWpGaD
Budesonide—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	7.1e-05	0.000908	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—GSTM1—lung cancer	7.08e-05	0.000905	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	6.98e-05	0.000893	CbGpPWpGaD
Budesonide—Nausea—Doxorubicin—lung cancer	6.93e-05	0.000169	CcSEcCtD
Budesonide—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	6.72e-05	0.00086	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	6.71e-05	0.000858	CbGpPWpGaD
Budesonide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	6.62e-05	0.000846	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—NOTCH3—lung cancer	6.43e-05	0.000823	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—JUNB—lung cancer	6.09e-05	0.000779	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AZIN2—lung cancer	5.9e-05	0.000755	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—COL4A3BP—lung cancer	5.9e-05	0.000755	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ATP5H—lung cancer	5.02e-05	0.000642	CbGpPWpGaD
Budesonide—CYP3A4—Biological oxidations—POMC—lung cancer	5e-05	0.00064	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PLBD1—lung cancer	4.47e-05	0.000572	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—ERCC2—lung cancer	4.42e-05	0.000566	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HSD17B10—lung cancer	4.09e-05	0.000523	CbGpPWpGaD
Budesonide—NR3C1—Generic Transcription Pathway—MYC—lung cancer	3.99e-05	0.00051	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CKB—lung cancer	3.8e-05	0.000486	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM2—lung cancer	3.57e-05	0.000457	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CNDP2—lung cancer	3.57e-05	0.000457	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—MTMR3—lung cancer	3.48e-05	0.000445	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PGAM1—lung cancer	3.39e-05	0.000434	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—CREBBP—lung cancer	3.24e-05	0.000414	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2A7—lung cancer	3.23e-05	0.000414	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—SDC4—lung cancer	3.16e-05	0.000405	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA3—lung cancer	2.88e-05	0.000369	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—RRM1—lung cancer	2.88e-05	0.000369	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—B4GALT5—lung cancer	2.71e-05	0.000347	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA4—lung cancer	2.64e-05	0.000337	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA2—lung cancer	2.57e-05	0.000329	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTA1—lung cancer	2.48e-05	0.000317	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCC3—lung cancer	2.45e-05	0.000313	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKR1C1—lung cancer	2.37e-05	0.000304	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—UGT1A1—lung cancer	2.3e-05	0.000295	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GNG11—lung cancer	2.22e-05	0.000284	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALDOA—lung cancer	2.12e-05	0.000271	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NCOA3—lung cancer	2.05e-05	0.000263	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCG2—lung cancer	2e-05	0.000256	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ADCY1—lung cancer	2e-05	0.000256	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MAPK3—lung cancer	1.98e-05	0.000253	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—HPGDS—lung cancer	1.96e-05	0.000251	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENO2—lung cancer	1.96e-05	0.000251	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.95e-05	0.000249	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—MYC—lung cancer	1.92e-05	0.000246	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTT1—lung cancer	1.9e-05	0.000243	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GCLC—lung cancer	1.88e-05	0.00024	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.88e-05	0.00024	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ENO1—lung cancer	1.78e-05	0.000228	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.6e-05	0.000204	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—NQO1—lung cancer	1.58e-05	0.000202	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—STK11—lung cancer	1.42e-05	0.000182	CbGpPWpGaD
Budesonide—NR3C1—Gene Expression—AKT1—lung cancer	1.33e-05	0.00017	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTP1—lung cancer	1.32e-05	0.000168	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CAT—lung cancer	1.28e-05	0.000164	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ABCB1—lung cancer	1.25e-05	0.000159	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—TYMS—lung cancer	1.22e-05	0.000157	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—GSTM1—lung cancer	1.21e-05	0.000155	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CYP1A1—lung cancer	1.15e-05	0.000147	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ERCC2—lung cancer	1.14e-05	0.000146	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—APOA1—lung cancer	9.84e-06	0.000126	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CG—lung cancer	8.99e-06	0.000115	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—POMC—lung cancer	8.55e-06	0.000109	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—CREBBP—lung cancer	8.33e-06	0.000107	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CD—lung cancer	7.9e-06	0.000101	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—ALB—lung cancer	7.8e-06	9.98e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CB—lung cancer	6.89e-06	8.81e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTGS2—lung cancer	6.82e-06	8.73e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PTEN—lung cancer	5.95e-06	7.61e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—EP300—lung cancer	5.67e-06	7.26e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—PIK3CA—lung cancer	4.2e-06	5.37e-05	CbGpPWpGaD
Budesonide—CYP3A4—Metabolism—AKT1—lung cancer	3.43e-06	4.39e-05	CbGpPWpGaD
